Last reviewed · How we verify
NCT04548479
A Comparative Study of Incentive Spirometry and Positive Expiratory Pressure in Chest Trauma
NA trial testing PEP bottle in Trauma Chest in 90 participants. Completed in 1 September 2022.
1 September 2022
Quick facts
| Lead sponsor | Hospital de Granollers |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 90 |
| Start date | 3 March 2020 |
| Primary completion | 1 September 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- PEP bottle
Conditions studied
- Trauma Chest — all drugs for Trauma Chest →
Sponsor
Hospital de Granollers
Who can join
Adults 18 to 88, any sex, with Trauma Chest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chest trauma (CT) patients with 3 or more ribs fractures with or without pleuropulmonary injury are an indicator of severity. Chest physiotherapy (CP) and analgesia is the first line treatment in these patients. The aim study is to evaluate the effect of positive expiratory pressure (PEP) breathing compared to the incentive spirometry in terms of pain control in the recent phase of CT.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04548479
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Trauma Chest
Currently open trials in the same condition.
- NCT06196125 — Ventilation dIstribution and effeCt of posTural Lateralization On Traumatic Lung injuRY: a Physiological Study · active not recruiting
- NCT05226858 — Transesophageal Echocardiography To Diagnose Blunt Traumatic Aortic Injury Traumatic Aortic Injury · recruiting
Other Hospital de Granollers trials
Trials by the same sponsor.
- NCT07486206 — Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial · NA · recruiting
- NCT07482917 — Optimizing the Diagnostic Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-1 Trial · NA · recruiting
- NCT07130656 — AI Algorithm for Surveillance of Deep Surgical Site Infections After Elective Colorectal Surgery. · recruiting
- NCT06626399 — ChatGPT-4 for Surgical Site Infection Detection From Electronic Health Records After Colorectal Surgery. · recruiting
- NCT06556017 — Assessment of the Efficacy of ChatGPT in Detecting Surgical Site Infections Following Elective Colorectal Surgery · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04548479 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital de Granollers
- Last refreshed: 14 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04548479.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing